The success rate of cancer clinical trials presently stands below 5%. Latest studies indicate that use of biomarkers to stratify patients entering clinical trial can improve success rate up to 2 times. Traditionally, a limited number of biomarkers (1 to 3) is used to identify responsive patients. Our approach will allow integrating information about the status of thousands of DNA and RNA markers to predict patient response with high accuracy using large scale mathematical models of cell type specific signalling networks in cancer. Other model applications include prediction of drug resistance mechanisms and new target identification.
Company Details
- Founded
- -
- Address
- Synergy Center, Tu Dublin, Tallaght, Dublin 24, Dublin,ireland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellgebra.com
- HQ
- Dublin
Cellgebra Questions
Cellgebra's website is http://www.cellgebra.com
Cellgebra's LinkedIn profile is https://ie.linkedin.com/company/cellgebra
Cellgebra's industry is
Biotechnology Research
Cellgebra's top competitors are
Probmet Therapeutics,
Lava Therapeutics N.v.,
Oncolize,
Cptx,
Lep Biomedical,
Cellclar Cic,
Phyxiom,
Priothera Sas,
Inthelia Therapeutics,
Pumpinheart.
Cellgebra's categories are Biotechnology Research
Cellgebra's founding year is 2020
